您的位置: 首页 > 农业专利 > 详情页

FARMACEUTSKE FORMULACIJE KOJE SADRŽE DAPAGLIFLOZIN PROPILEN GLIKOL HIDRAT
专利权人:
AstraZeneca AB
发明人:
Bindra, Dilbir S.,Dali, Mandar V.,Parab, Prakash V.,PATEL, Jatin, M.,Tao, Li,Tejwani, Ravindra W.,Vatsaraj, Nipa,Wu, Yongmei
申请号:
HRP20200753
公开号:
HRP20200753T1
申请日:
2020.05.11
申请国别(地区):
HR
年份:
2020
代理人:
摘要:
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include dapagliflozin propylene glycol hydrate is: Formula (Ia) or Formula (Ib) and a pharmaceutical acceptable carrier therefore, which formulation is designed for immediate release. The formulations are used for the treatment of diabetes and related diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充